PROXY STATEMENT

Company

CERO THERAPEUTICS HOLDINGS, INC.

Filed

October 15, 2024

Period of Report

November 4, 2024

Accession Number

0001213900-24-087416

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →